Transcatheter Closure of Atrial Septal Defect with Carag Bioresorbable Septal Occluder™: First-in-Child Experience with 12-MonthFollow-Up

BACKGROUND: Nowadays, transcatheter device closure of an atrial septal defect (ASD) is a standard approach in children. Potential early and long-term side effects or complications related to the metal framework of the devices are a known issue. A bioresorbable device such as the Carag Bioresorbable...

Descripción completa

Detalles Bibliográficos
Autores principales: Callegari, Alessia, Quandt, Daniel, Nordmeyer, Johannes, Schubert, Stephan, Kramer, Peter, Knirsch, Walter, Kretschmar, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822760/
https://www.ncbi.nlm.nih.gov/pubmed/36684829
http://dx.doi.org/10.1155/2022/3476398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822760/
https://www.ncbi.nlm.nih.gov/pubmed/36684829
http://dx.doi.org/10.1155/2022/3476398

Ejemplares similares